Abstract:In this review, we provide a comprehensive overview of the neurochemical systems implicated in depressive disorders and emphasize the need to gain a better understanding in order to develop more effective treatments. Moreover, we present a range of techniques for monitoring neurochemical release, with a particular focus on the recently developed genetically encoded neurochemical sensors. These sensors offer a valuable opportunity to monitor neurochemical dynamics in vivo with high spatial–temporal resolution. Additionally, we delve into recent depression studies that utilized these neurochemical sensors and discuss potential improvements that can be implemented to better meet the specific needs of studying depression. Depressive disorders are a common and debilitating form of mental illness with significant impacts on individuals and society. Despite the high prevalence, the underlying causes and mechanisms of depressive disorders are still poorly understood. Neurochemical systems, including serotonin, norepinephrine, and dopamine, have been implicated in the development and perpetuation of depressive symptoms. Current treatments for depression target these neuromodulator systems, but there is a need for a better understanding of their role in order to develop more effective treatments. Monitoring neurochemical dynamics during depressive symptoms is crucial for gaining a better a understanding of their involvement in depressive disorders. Genetically encoded sensors have emerged recently that offer high spatial–temporal resolution and the ability to monitor neurochemical dynamics in real time. This review explores the neurochemical systems involved in depression and discusses the applications and limitations of current monitoring tools for neurochemical dynamics. It also highlights the potential of genetically encoded sensors for better characterizing neurochemical dynamics in depression‐related behaviors. Furthermore, potential improvements to current sensors are discussed in order to meet the requirements of depression research.

A Critical Review of Carbon Quantum Dots: From Synthesis toward Applications in Electrochemical Biosensors for the Determination of a Depression-Related Neurotransmitter

Carbon quantum dots: synthesis, properties, and sensing applications as a potential clinical analytical method

Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression

Review—Electrochemical Immunosensors for Depression Markers Detection: Development in Recent Years

Recent advances in carbon dots for electrochemical sensing and biosensing: A systematic review

Electrochemical Chemically Based Sensors and Emerging Enzymatic Biosensors for Antidepressant Drug Detection: A Review

Carbon Dots-Based Dopamine Sensors: Recent Advances and Challenges

Recent Developments of Carbon Dots in Biosensing: A Review

Advances in biosensors for major depressive disorder diagnostic biomarkers

Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression

A critical review on quantum dots: From synthesis toward applications in electrochemical biosensors for determination of disease-related biomolecules

Carbon Dots in Bioimaging, Biosensing and Therapeutics: A Comprehensive Review

Review on carbon dots: Synthesis and application in biology field

Advances in the application of carbon dots-based fluorescent probes in disease biomarker detection

Review on Carbon Dot-Based Fluorescent Detection of Biothiols

Recent Progress in Biosensors for Depression Monitoring—Advancing Personalized Treatment

Electrochemical Synthesis of Carbon Quantum Dots

Vacancy-Driven High-Performance Metabolic Assay for Diagnosis and Therapeutic Evaluation of Depression

Carbon‐based Nanodots for Biomedical Applications and Clinical Transformation Prospects

A Review of Dual-Emission Carbon Dots and Their Applications

Recent Research Progress of Fluorescence Biosensors Based on Carbon Dots in Early Diagnosis of Diseases